Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Protective effects of atorvastatin on chronic allograft nephropathy in rats.

Protective effects of atorvastatin on chronic allograft nephropathy in rats. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Protective effects of atorvastatin on chronic allograft nephropathy in rats. Abstract Text:

    wei zhangWei Zhang,min liuMin Liu,yichao wuYichao Wu,pengcheng zhuPengcheng Zhu,changjun yinChangjun Yin,wei zhangWei Zhang,min guMin Gu,wei zhangWei Zhang,min liuMin Liu,yichao wuYichao Wu,pengcheng zhuPengcheng Zhu,changjun yinChangjun Yin,wei zhangWei Zhang,min guMin Gu,wei zhangWei Zhang,min liuMin Liu,yichao wuYichao Wu,pengcheng zhuPengcheng Zhu,changjun yinChangjun Yin,wei zhangWei Zhang,min guMin Gu,

    OBJECTIVE: Chronic allograft nephropathy (CAN) is the leading cause of late kidney allograft loss. Recent studies have suggested that atorvastatin (ATO) may interact with the acute inflammatory process in the renal interstitium and suppress the proliferation of mesangial cells. We hypothesized that ATO could also inhibit the chronic inflammatory process and prevent the progression of CAN. MATERIALS AND METHODS: Fisher (F344) kidneys were orthotopically transplanted into Lewis rat recipients. Lewis-to-Lewis rat kidney transplantation was served as the syngeneic control (Syn group). Allograft recipients were randomized and treated with cyclosporine A alone (Allo group) or in combination with ATO (15 or 30 mg/kg/d intrgastric, respectively, the low dose treatment group/high dose treatment group [LT/HT] groups). Renal function and the urine protein excretion were analyzed. Animals were sacrificed 20 weeks posttransplantation for histological and immunohistochemical studies, as well as analysis of mRNA levels of cytokines and chemokines. RESULTS: Renal function progressively deteriorated and substantial proteinuria developed in the Allo group compared with the Syn group. ATO-treated rats had significantly higher creatinine clearance rate and less amount of proteinuria. Histological examination revealed obvious features of CAN in the Allo group, whereas LT/HT groups demonstrated minimal glomerulosclerosis, interstitial fibrosis, intimal thickening, and tubular atrophy. The numbers of infiltrating mononuclear cells (ED1+, CD8+, and CD68+) decreased markedly, and the intragraft expression of transforming growth factor beta1 (TGF-beta1) and collagen III were also significantly attenuated in the LT/HT groups, as compared with the Allo group. The mRNA levels of proinflammatory cytokines (interleukin-2, interferon-gamma, interleukin-10), chemokines (RANTES, MCP-1), and profibrotic genes (TGF-beta1, collagen III) were significantly down-regulated in ATO-treated rats. CONCLUSION: Atorvastatin showed excellent favorable effects on blocking renal inflammation and fibrosis, and thus, efficiently inhibited the development and progression of CAN, which might improve the long-term survival rate of renal allografts.

    Protective effects of atorvastatin on chronic allograft nephropathy in rats. Publishing Authors By Initials

    w zhangW Zhang,m liuM Liu,y wuY Wu,p zhuP Zhu,c yinC Yin,w zhangW Zhang,m guM Gu,w zhangW Zhang,m liuM Liu,y wuY Wu,p zhuP Zhu,c yinC Yin,w zhangW Zhang,m guM Gu,w zhangW Zhang,m liuM Liu,y wuY Wu,p zhuP Zhu,c yinC Yin,w zhangW Zhang,m guM Gu,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Protective effects of atorvastatin on chronic allograft nephropathy in rats. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: The Journal of surgical research

    VOLUME: 143

    Page Numbers: 428-36

    Journal Abbreviation: J. Surg. Res.

    ISSN: 0022-4804

    DAY: 12

    MONTH: 07

    YEAR: 2007

    Protective effects of atorvastatin on chronic allograft nephropathy in rats. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 376340

    Protective effects of atorvastatin on chronic allograft nephropathy in rats. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Protective effects of atorvastatin on chronic allograft nephropathy in rats. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Protective effects of atorvastatin on chronic allograft nephropathy in rats.

    AFFILIATION: Division of Urology and Kidney Transplantation, Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Surg Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Protective effects of atorvastatin on chronic allograft nephropathy in rats Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News